• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Alimera Sciences Inc

+ Add to Watchlist

ALIM:US

6.1600 USD 0.0500 0.82%

As of 15:25:02 ET on 04/24/2014.

Snapshot for Alimera Sciences Inc (ALIM)

Open: 6.1900 Day's Range: 6.0000 - 6.2800 Volume: 102,924
Previous Close: 6.1100 52wk Range: 1.6500 - 8.4400 1-Yr Rtn: +106.73%

Stock Chart for ALIM

No chart data available.
  • ALIM:US 6.1600
  • 1D
  • 1M
  • 1Y
6.1100
Interactive ALIM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALIM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2051
Est. EPS (USD) (12/2014) -0.7750
Est. PEG Ratio -
Market Cap (M USD) 250.28
Shares Outstanding (M) 40.30
30 Day Average Volume 277,336
Price/Book (mrq) -
Price/Sale (ttm) 103.6352
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALIM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALIM

Alimera Sciences Inc. is a biopharmaceutical company. The Company researches, develops and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the lining in the back of the eye, or retina.

Philip R Tracy "Phil"ChairmanC Daniel Myers "Dan"President/CEO/Co-Founder
Richard S Eiswirth Jr "Rick"CFO/COO/SecretaryKenneth Green "Ken"Senior VP/Chief Scientific Ofcr
More Company Profile & Key Executives for ALIM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil